Researchers have created the world’s most detailed atlas of the genetic code of the human retina, and it could help treat and prevent blindness
The transcriptome of human neural retina at a single‐cell level defines the gene expression profile in major cell types in the neural retina and can be used as a benchmark to assess the quality of stem cell‐derived cells or primary retinal cells.
- The presented transcriptome atlas of human neural retina comprises single‐cell RNA‐sequencing data from 20,009 human retinal cells.
- Unsupervised cell clustering analysis allows identification of 18 transcriptionally distinct cell populations that represent all known neural retinal cell types.
- Reduced expression of the long non‐coding RNA MALAT1 correlates with longer post‐mortem time in putative early degenerating rod photoreceptors.
- The retina transcriptome atlas can be used to benchmark pluripotent stem cell‐derived cone photoreceptors and an adult Müller glia cell line.
Many different things can cause blindness.
Often, it’s related to ageing with conditions like glaucoma, age-related macular degeneration or severe cataracts stealing sight. Sometimes it’s the result of eye injury or infection, or a complication of diabetes.
But for younger people, the cause of blindness is most often genetic. Millions of working-age people worldwide are affected by inherited retinal diseases (IRDs) like retinitis pigmentosa, macular dystrophy, or a range of rarer genetic conditions.
The University of Melbourne and Centre for Eye Research Australia have contributed to a new genetic map of the retina, revealing vital clues that will aid future research to prevent and treat blindness.
The map is the world’s most detailed look at the genetic code of the human retina.
Researchers worldwide will be able to use this genetic atlas to gain unprecedented insights into eye disease, opening up new approaches to preventing and treating blindness.
The retina is the thin layer of tissue at the back of the eye, made up of millions of cells that work together to process light and transmit signals to the brain via the optic nerve.
Vision loss from inherited retinal diseases can be sudden or gradual, and partial or complete and there is a lot we still don’t know about what causes these diseases.
This makes preventing and treating blindness a significant scientific challenge.
WHAT IS INHERITED RETINAL DISEASE?
To understand blindness, let’s first look at how vision works. Essentially, the eye functions like a camera, capturing light and converting it to electrical signals for the brain to interpret as images.
This all happens in a tiny fraction of a second – so fast we comprehend it as instant. But, if any part of this complex process is impaired, vision loss can occur.
For inherited retinal diseases, the problem occurs in the retina. Inherited retinal diseases occur when genetic ‘mistakes’ cause retinal cells to stop functioning correctly.
Over time, the photoreceptor (light-sensing) cells can die, leading to vision loss and blindness.
More than 200 genes are known to be associated with retinal diseases. These genetic errors can be passed down from parent to child, but this doesn’t always result in disease.
This means an inherited retinal disease can strike even when there is no known family history of it. It seems to come out of nowhere but the genetic imperfection has been silently lurking in the family tree.
THE RETINAL MAP
Our new retinal atlas provides new insights into the genetic code of the cells in the human retina.
Our research, published this week in European Molecular Biological Organisation (EMBO) Journal, is a collaboration which I led with Dr Samuel Lukowski from the Institute for Molecular Science at the University of Queensland and Associate Professor Joseph Powell from the Garvan Institute of Medical Research.
To create this map, we examined the complex genetic sequences behind more than 20,000 individual retinal cells.
This allowed us to develop a genetic profile of the major cell types in the retina, and the genes they express to function normally.
Cells mapped include photoreceptors, which sense light and allow people to see, as well as retinal ganglion cells, which transmit messages to the brain along the optic nerve, and other cells that support the function and stability of the retina.
A GLOBAL APPROACH
This study is part of the Human Cell Atlas, a global project that aims to create comprehensive reference maps of all human cells to better understand, diagnose and treat disease.
This is the first time an Australian group has contributed to the initiative, and the retina is the first part of the eye to be mapped in the project.
We have now formed the ANZ Human Eye Cell Atlas Consortium, bringing together scientists from 20 partnering institutes and universities across Australia and New Zealand with the goal of creating reference maps for different parts of the human eye.
THE FUTURE OF RESEARCH INTO BLINDNESS
Now that we have a detailed map of a healthy retina, we can use this to advance our understanding of what goes wrong in inherited retinal diseases.
Having a detailed gene profile of individual retinal cell types will help us study how these genes impact different kinds of cells, and what genetic signals cause a cell to stop functioning, leading to vision loss and blindness.
The atlas will also help scientists exploring the emerging area of cell therapy, which could replace faulty retinal cells with new cells developed from stem cells in the lab.
The retinal cell map will give scientists a clear benchmark to assess the quality of cells derived from stem cells and to determine whether they have the correct genetic code to enable them to function.
With this new knowledge, we’re one step closer to better identifying what causes blinding eye disease, and to ultimately developing treatments and cures.